Institutional investors purchased a net $7.4 million shares of GILD during the quarter ended June 2017 and now own 78.19% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BARCLAYS BANK PLC (PRIVATE BANKI... Bought 4.3 Million shares of Gilead Sciences
OPPENHEIMERFUNDS, INC. Bought 3.7 Million shares of Gilead Sciences
AQR CAPITAL MANAGEMENT LLC Bought 3.5 Million shares of Gilead Sciences